BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12398975)

  • 1. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.
    Bollmann A; Binias KH; Toepffer I; Molling J; Geller C; Klein HU
    Am J Cardiol; 2002 Nov; 90(9):1011-4. PubMed ID: 12398975
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilot study: Noninvasive monitoring of oral flecainide's effects on atrial electrophysiology during persistent human atrial fibrillation using the surface electrocardiogram.
    Husser D; Binias KH; Stridh M; Sornmo L; Olsson SB; Molling J; Geller C; Klein HU; Bollmann A
    Ann Noninvasive Electrocardiol; 2005 Apr; 10(2):206-10. PubMed ID: 15842433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
    Boriani G; Biffi M; Capucci A; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Magnani B
    J Am Coll Cardiol; 1999 Feb; 33(2):333-41. PubMed ID: 9973012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.
    Limantoro I; De Vos CB; Delhaas T; Marcos E; Blaauw Y; Weijs B; Tieleman RG; Pisters R; Schotten U; Van Gelder IC; Crijns HJ
    Heart Rhythm; 2014 Mar; 11(3):478-84. PubMed ID: 24321238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
    Nattel S
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
    [No Abstract]   [Full Text] [Related]  

  • 6. Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.
    Hegde S; Kumar V
    JAMA Intern Med; 2016 Mar; 176(3):386-8. PubMed ID: 26784121
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled Oral Flecainide for Rapid Cardioversion of Atrial Fibrillation.
    Kiani S
    JACC Clin Electrophysiol; 2024 Jun; 10(6):1034-1036. PubMed ID: 38795097
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal intractable atrial flutter successfully treated with intravenous flecainide.
    Suzumura H; Nitta A; Ono M; Arisaka O
    Pediatr Cardiol; 2004; 25(2):154-6. PubMed ID: 14681740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-current cardioversion of atrial tachyarrhythmias under oral flecainide therapy.
    Leclercq JF; Bizot J; Attuel P; Coumel P
    Am J Cardiol; 1997 Sep; 80(5):645-8. PubMed ID: 9295002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of a left-sided accessory pathway during atrial fibrillation facilitated by intravenous flecainide.
    Ng GA; Rankin AC
    J Interv Card Electrophysiol; 1999 Oct; 3(3):279-82. PubMed ID: 10490486
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
    Nabar A; Rodriguez LM; Timmermans C; Smeets JL; Wellens HJ
    Am J Cardiol; 1999 Mar; 83(5):785-7, A10. PubMed ID: 10080440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.
    De Vos CB; Limantoro I; Pisters R; Delhaas T; Schotten U; Cheriex EC; Tieleman RG; Crijns HJ
    Heart Rhythm; 2014 Sep; 11(9):1514-21. PubMed ID: 24768608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.
    Oto E; Okutucu S; Katircioglu-Öztürk D; Güvenir HA; Karaagaoglu E; Borggrefe M; Breithardt G; Goette A; Ravens U; Steinbeck G; Wegscheider K; Oto A; Kirchhof P
    Europace; 2017 Jun; 19(6):921-928. PubMed ID: 27377074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model.
    Verrier RL; Bortolotto AL; Silva BA; Marum AA; Stocco FG; Evaristo E; de Antonio VZ; Silva AC; Belardinelli L
    Heart Rhythm; 2018 Dec; 15(12):1882-1888. PubMed ID: 29958990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic atrial fibrillation of recent onset and atrial stunning: the echocardiographic evidence after pharmacological cardioversion].
    Ciolli A; De Sisti A; Montenero AS; Sanna T; Lo Sardo G; Palamara A
    Cardiologia; 1998 Oct; 43(10):1077-82. PubMed ID: 9922572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
    Kanemoto M; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kakugawa H; Kametani R; Inoue N; Sawa A; Matsuzaki M
    Cardiovasc Drugs Ther; 2004 Jul; 18(4):295-303. PubMed ID: 15367827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
    Crijns HJ; Van Gelder IC; Kingma JH; Dunselman PH; Gosselink AT; Lie KI
    Eur Heart J; 1994 Oct; 15(10):1403-8. PubMed ID: 7821320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH; Kunze KP; Schlüter M; Duckeck W
    Am J Cardiol; 1988 Dec; 62(19):37L-44L. PubMed ID: 3144166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.